June 03, 2024 09:57 GMT
Becton Dickinson (BDX: Baa2/ BBB / BBB): Acquisition
HEALTHCARE
Buying Edward Lifesciences' Critical Care Unit for $4.2b
- Will issue $3.2b of new debt and use $1b of cash.
- At closing, BD is expected to have net leverage of approximately 3x
- Expects to de-lever to its 2.5x long-term net leverage target within 12 to 18 months of closing, primarily by deploying its free cash flows to debt repayment.
56 words